Antiviral Evaluation of New Synthetic Bioconjugates Based on GA-Hecate: A New Class of Antivirals Targeting Different Steps of Zika Virus Replication.

MLA

da Silva Sanches, Paulo Ricardo, et al. “Antiviral Evaluation of New Synthetic Bioconjugates Based on GA-Hecate: A New Class of Antivirals Targeting Different Steps of Zika Virus Replication.” Molecules, vol. 28, no. 13, July 2023, p. 4884. EBSCOhost, https://doi.org/10.3390/molecules28134884.

APA

da Silva Sanches, P. R., Sanchez-Velazquez, R., Batista, M. N., Carneiro, B. M., Bittar, C., De Lorenzo, G., Rahal, P., Patel, A. H., & Cilli, E. M. (2023). Antiviral Evaluation of New Synthetic Bioconjugates Based on GA-Hecate: A New Class of Antivirals Targeting Different Steps of Zika Virus Replication. Molecules, 28(13), 4884. https://doi.org/10.3390/molecules28134884

Chicago

da Silva Sanches, Paulo Ricardo, Ricardo Sanchez-Velazquez, Mariana Nogueira Batista, Bruno Moreira Carneiro, Cintia Bittar, Giuditta De Lorenzo, Paula Rahal, Arvind H. Patel, and Eduardo Maffud Cilli. 2023. “Antiviral Evaluation of New Synthetic Bioconjugates Based on GA-Hecate: A New Class of Antivirals Targeting Different Steps of Zika Virus Replication.” Molecules 28 (13): 4884. doi:10.3390/molecules28134884.